Physician profile
Ryan D Wells
NPI 1184697658
$756.24
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.71 · 2020: $15.58 · 2021: $174 · 2022: $438 · 2024: $65.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $42.99 · Food and Beverage: $22.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $42.99 |
| Food and Beverage | $22.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $155.28 | 2021-2022 | |
| Janssen Biotech, INC. | $146.56 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $117.67 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $91.10 | 2019-2022 | |
| Amgen INC. | $87.38 | 2021-2022 | |
| Genzyme Corporation | $66.91 | 2022 | |
| Epi Health, LLC | $29.78 | 2019-2020 | |
| Ucb, INC. | $24.61 | 2021 | |
| Mimedx Group, INC. | $22.04 | 2024 | |
| Incyte Corporation | $14.91 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.